Summary of findings table ‐ Continuation vs reduction of polypharmacy
Functioning at · patients with schizophrenia
1 finding from 1 review
- Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 12 participantsVery low